On 4 February 2015
Alembic Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 4 February 2015, to consider and approve the Unaudited Financial Results of the Company for the Quarter ended 31 December 2014 (Q3).Powered by Capital Market - Live News
